Author： Dierkes Jutta Westphal Sabine Luley Claus
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.3, Iss.2, 2004-03, pp. : 101-111
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Era of Statins – Is There Still a Place for Other Classes of Lipid-Lowering Drugs?
Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. :
Access to resources
Recommend
New prospects for lipid-lowering drugs
By Thompson G.R. Naoumova R.P.
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. :
Patients are less likely to receive lipid-lowering drugs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. :
A New Class of Lipid-Lowering Drugs: Ezetimibe
Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. :